Publications

  1. Hinshaw L, Schiavon M, Mallad A, Man CD, Basu R, Bharucha AE, Cobelli C, Carter RE, Basu A, Kudva YC. Effects of Delayed Gastric Emptying on Postprandial Glucose Kinetics, Insulin Sensitivity and Beta Cell Function. Am J Physiol Endocrinol Metab. 2014 Jul 29.
    View PubMed
  2. Curry TB, Hines CN, Barnes JN, Somaraju M, Basu R, Miles JM, Joyner MJ, Charkoudian N. Relationship of muscle sympathetic nerve activity to insulin sensitivity. Clin Auton Res. 2014 Apr; 24(2):77-85. Epub 2014 Mar 01.
    View PubMed
  3. Dube S, Norby B, Pattan V, Lingineni RK, Singh RJ, Carter RE, Basu A, Basu R. Hepatic 11 beta-hydroxysteroid dehydrogenase type 1 activity in obesity and type 2 diabetes using a novel triple tracer cortisol technique. Diabetologia. 2014; 57(7):1446-55.
  4. Basu A, Dube S, Slama M, Errazuriz I, Amezcua JC, Kudva YC, Peyser T, Carter RE, Cobelli C, Basu R. Time lag of glucose from intravascular to interstitial compartment in humans. Diabetes. 2013 Dec; 62(12):4083-7. Epub 2013 Sep 05.
    View PubMed
  5. Abdelmoneim SS, Hagen ME, Mendrick E, Pattan V, Wong B, Norby B, Roberson T, Szydel T, Basu R, Basu A, Mulvagh SL. Acute hyperglycemia reduces myocardial blood flow reserve and the magnitude of reduction is associated with insulin resistance: a study in nondiabetic humans using contrast echocardiography. Heart Vessels. 2013 Nov; 28(6):757-68. Epub 2012 Nov 23.
    View PubMed
  6. Rajpal A, Dube S, Carvalho F, Simoes AR, Figueiredo A, Basu A, Jones J, Basu R. Effects of transaldolase exchange on estimates of gluconeogenesis in type 2 diabetes. Am J Physiol Endocrinol Metab. 2013 Aug 15; 305(4):E465-74. Epub 2013 Jun 04.
    View PubMed
  7. Schiavon M, Hinshaw L, Mallad A, Dalla Man C, Sparacino G, Johnson M, Carter R, Basu R, Kudva Y, Cobelli C, Basu A. Postprandial glucose fluxes and insulin sensitivity during exercise: a study in healthy individuals. Am J Physiol Endocrinol Metab. 2013 Aug 15; 305(4):E557-66. Epub 2013 Jul 02.
    View PubMed
  8. Barosa C, Jones JG, Rizza R, Basu A, Basu R. Acetaminophen glucuronide and plasma glucose report identical estimates of gluconeogenesis and glycogenolysis for healthy and prediabetic subjects using the deuterated water method. Magn Reson Med. 2013 Aug; 70(2):315-9. Epub 2012 Sep 28
    View PubMed
  9. Hinshaw L, Dalla Man C, Nandy DK, Saad A, Bharucha AE, Levine JA, Rizza RA, Basu R, Carter RE, Cobelli C, Kudva YC, Basu A. Diurnal pattern of insulin action in type 1 diabetes: implications for a closed-loop system. Diabetes. 2013 Jul; 62(7):2223-9. Epub 2013 Feb 27.
    View PubMed
  10. Dube S, Errazuriz I, Cobelli C, Basu R, Basu A. Assessment of insulin action on carbohydrate metabolism: physiological and non-physiological methods. Diabet Med. 2013 Jun; 30(6):664-70.
    View PubMed
  11. Dalla Man C, Piccinini F, Basu R, Basu A, Rizza RA, Cobelli C. Modeling hepatic insulin sensitivity during a meal: validation against the euglycemic hyperinsulinemic clamp. Am J Physiol Endocrinol Metab. 2013 Apr 15; 304(8):E819-25. Epub 2013 Feb 26.
    View PubMed
  12. Winnick JJ, Ramnanan CJ, Saraswathi V, Roop J, Scott M, Jacobson P, Jung P, Basu R, Cherrington AD, Edgerton DS. Effects of 11beta-hydroxysteroid dehydrogenase-1 inhibition on hepatic glycogenolysis and gluconeogenesis. Am J Physiol Endocrinol Metab. 2013 Apr 1; 304(7):E747-56. Epub 2013 Feb 12.
    View PubMed
  13. Basu R, Barosa C, Jones J, Dube S, Carter R, Basu A, Rizza RA. Pathogenesis of prediabetes: role of the liver in isolated fasting hyperglycemia and combined fasting and postprandial hyperglycemia. J Clin Endocrinol Metab. 2013 Mar; 98(3):E409-17. Epub 2013 Jan 23.
    View PubMed
  14. Basu A, Kudva YC, Basu R. GPR40 modulators: new kid on the block. Diabetes Care. 2013 Feb; 36(2):185-7.
    View PubMed
  15. Katz DA, Liu W, Locke C, Jacobson P, Barnes DM, Basu R, An G, Rieser MJ, Daszkowski D, Groves F, Heneghan G, Shah A, Gevorkyan H, Jhee SS, Ereshefsky L, Marek GJ. Peripheral and central nervous system inhibition of 11beta-hydroxysteroid dehydrogenase type 1 in man by the novel inhibitor ABT-384. Transl Psychiatry. 2013; 3:e295. Epub 2013 Aug 27.
    View PubMed
  16. Manohar C, Levine JA, Nandy DK, Saad A, Dalla Man C, McCrady-Spitzer SK, Basu R, Cobelli C, Carter RE, Basu A, Kudva YC. The effect of walking on postprandial glycemic excursion in patients with type 1 diabetes and healthy people. Diabetes Care. 2012 Dec; 35(12):2493-9. Epub 2012 Aug 08.
    View PubMed
  17. Short KR, Irving BA, Basu A, Johnson CM, Nair KS, Basu R. Effects of type 2 diabetes and insulin on whole-body, splanchnic, and leg protein metabolism. J Clin Endocrinol Metab. 2012 Dec; 97(12):4733-41. Epub 2012 Oct 02.
    View PubMed
  18. Bush NC, Basu R, Rizza RA, Nair KS, Khosla S, Jensen MD. Insulin-mediated FFA suppression is associated with triglyceridemia and insulin sensitivity independent of adiposity. J Clin Endocrinol Metab. 2012 Nov; 97(11):4130-8. Epub 2012 Aug 29.
    View PubMed
  19. Saad A, Dalla Man C, Nandy DK, Levine JA, Bharucha AE, Rizza RA, Basu R, Carter RE, Cobelli C, Kudva YC, Basu A. Diurnal pattern to insulin secretion and insulin action in healthy individuals. Diabetes. 2012 Nov; 61(11):2691-700. Epub 2012 Jun 29.
    View PubMed
  20. Kehlenbrink S, Koppaka S, Martin M, Relwani R, Cui MH, Hwang JH, Li Y, Basu R, Hawkins M, Kishore P. Elevated NEFA levels impair glucose effectiveness by increasing net hepatic glycogenolysis. Diabetologia. 2012 Nov; 55(11):3021-8. Epub 2012 Jul 31.
    View PubMed
  21. Keenan DM, Basu R, Liu Y, Basu A, Bock G, Veldhuis JD. Logistic model of glucose-regulated C-peptide secretion: hysteresis pathway disruption in impaired fasting glycemia. Am J Physiol Endocrinol Metab. 2012 Aug 1; 303(3):E397-409. Epub 2012 Jun 05.
    View PubMed
  22. Jensen MD, Nielsen S, Gupta N, Basu R, Rizza RA. Insulin clearance is different in men and women. Metabolism. 2012 Apr; 61(4):525-30. Epub 2011 Oct 13.
    View PubMed
  23. Wehrwein EA, Curry TB, Basu A, Rizza RA, Basu R, Joyner MJ. Do the carotid bodies modulate hypoglycemic counterregulation and baroreflex control of blood pressure in humans? Adv Exp Med Biol. 2012; 758:129-35.
    View PubMed
  24. Basu R, Peterson J, Rizza R, Khosla S. Effects of physiological variations in circulating insulin levels on bone turnover in humans. J Clin Endocrinol Metab. 2011 May; 96(5):1450-5. Epub 2011 Feb 16.
    View PubMed
  25. Manesso E, Toffolo GM, Basu R, Rizza RA, Cobelli C. Modeling nonsteady-state metabolism from arteriovenous data. IEEE Trans Biomed Eng. 2011 May; 58(5):1253-9. Epub 2010 Dec 03.
    View PubMed
  26. Curry TB, Roberts SK, Basu R, Basu A, Schroeder D, Joyner MJ, Miles JM. Gastric bypass surgery is associated with near-normal insulin suppression of lipolysis in nondiabetic individuals. Am J Physiol Endocrinol Metab. 2011 Apr; 300(4):E746-51. Epub 2011 Feb 08.
    View PubMed
  27. Basu R, Barosa C, Basu A, Pattan V, Saad A, Jones J, Rizza R. Transaldolase exchange and its effects on measurements of gluconeogenesis in humans. Am J Physiol Endocrinol Metab. 2011 Feb; 300(2):E296-303. Epub 2010 Nov 09.
    View PubMed
  28. Koutsari C, Basu R, Rizza RA, Nair KS, Khosla S, Jensen MD. Nonoxidative free fatty acid disposal is greater in young women than men. J Clin Endocrinol Metab. 2011 Feb; 96(2):541-7. Epub 2010 Dec 01.
    View PubMed
  29. Wehrwein E, Basu R, Basu A, Curry T, Rizza R, Joyner MJ. Erratum to "Hyperoxia blunts counterregulation during hypoglycemia in humans: possible role for the carotid bodies?" by Erica A Wehrwein, Rita Basu, Ananda Basu, Timothy B Curry, Robert A Rizza, and Michael J Joyner(doi:10.1113/jphysiol.2010.197491). J Physiol. 2010 Dec 13. [Epub ahead of print]
    View PubMed
  30. Wehrwein EA, Basu R, Basu A, Curry TB, Rizza RA, Joyner MJ. Hyperoxia blunts counterregulation during hypoglycaemia in humans: possible role for the carotid bodies? J Physiol. 2010 Nov 15; 588(Pt 22):4593-601. Epub 2010 Oct 04.
    View PubMed
  31. Basu A, Basu R, Pattan V, Rizza RA, Jensen MD. Meal fat storage in subcutaneous adipose tissue: comparison of pioglitazone and glipizide treatment of type 2 diabetes. Obesity (Silver Spring). 2010 Oct; 18(10):2058-60. Epub 2010 Jun 10.
    View PubMed
  32. Bock G, Dalla Man C, Micheletto F, Basu R, Giesler PD, Laugen J, Deacon CF, Holst JJ, Toffolo G, Cobelli C, Rizza RA, Vella A. The effect of DPP-4 inhibition with sitagliptin on incretin secretion and on fasting and postprandial glucose turnover in subjects with impaired fasting glucose. Clin Endocrinol (Oxf). 2010 Aug; 73(2):189-96. Epub 2009 Dec 18.
    View PubMed
  33. Edgerton DS, Basu R, Ramnanan CJ, Farmer TD, Neal D, Scott M, Jacobson P, Rizza RA, Cherrington AD. Effect of 11 beta-hydroxysteroid dehydrogenase-1 inhibition on hepatic glucose metabolism in the conscious dog. Am J Physiol Endocrinol Metab. 2010 May; 298(5):E1019-26. Epub 2010 Feb 16.
    View PubMed
  34. Campioni M, Toffolo GM, Basu R, Rizza RA, Cobelli C. MINIMAL MODEL ASSESSMENT OF HEPATIC INSULIN EXTRACTION DURING AN ORAL TEST FROM STANDARD INSULIN KINETIC PARAMETERS. Am J Physiol Endocrinol Metab. 2009 Aug 11. [Epub ahead of print]
    View PubMed
  35. Basu R, Chandramouli V, Schumann W, Basu A, Landau BR, Rizza RA. Additional evidence that transaldolase exchange, isotope discrimination during the triose-isomerase reaction, or both occur in humans: effects of type 2 diabetes. Diabetes. 2009 Jul; 58(7):1539-43. Epub 2009 Apr 14.
    View PubMed
  36. Basu A, Dalla Man C, Basu R, Toffolo G, Cobelli C, Rizza RA. Effects of type 2 diabetes on insulin secretion, insulin action, glucose effectiveness, and postprandial glucose metabolism. Diabetes Care. 2009 May; 32(5):866-72. Epub 2009 Feb 05.
    View PubMed
  37. Henderson GC, Dhatariya K, Ford GC, Klaus KA, Basu R, Rizza RA, Jensen MD, Khosla S, O'Brien P, Nair KS. Higher muscle protein synthesis in women than men across the lifespan, and failure of androgen administration to amend age-related decrements. FASEB J. 2009 Feb; 23(2):631-41. Epub 2008 Sep 30.
    View PubMed
  38. Basu R, Basu A, Grudzien M, Jung P, Jacobson P, Johnson M, Singh R, Sarr M, Rizza RA. Liver is the site of splanchnic cortisol production in obese nondiabetic humans. Diabetes. 2009 Jan; 58(1):39-45. Epub 2008 Oct 13.
    View PubMed
  39. Man CD, Toffolo G, Basu R, Rizza RA, Cobelli C. Use of labeled oral minimal model to measure hepatic insulin sensitivity. Am J Physiol Endocrinol Metab. 2008 Nov; 295(5):E1152-9. Epub 2008 Sep 02.
    View PubMed
  40. Basu R, Basu A, Chandramouli V, Norby B, Dicke B, Shah P, Cohen O, Landau BR, Rizza RA. Effects of pioglitazone and metformin on NEFA-induced insulin resistance in type 2 diabetes. Diabetologia. 2008 Nov; 51(11):2031-40. Epub 2008 Sep 04.
    View PubMed
  41. Lanza IR, Short DK, Short KR, Raghavakaimal S, Basu R, Joyner MJ, McConnell JP, Nair KS. Endurance exercise as a countermeasure for aging. Diabetes. 2008 Nov; 57(11):2933-42. Epub 2008 Aug 20.
    View PubMed
  42. Basu R, Chandramouli V, Dicke B, Landau BR, Rizza RA. Plasma C5 glucose-to-2H2O ratio does not provide an accurate assessment of gluconeogenesis during hyperinsulinemic-euglycemic clamps in either nondiabetic or diabetic humans. Diabetes. 2008 Jul; 57(7):1800-4. Epub 2008 Apr 16.
    View PubMed
  43. Bock G, Schumann WC, Basu R, Burgess SC, Yan Z, Chandramouli V, Rizza RA, Landau BR. Evidence that processes other than gluconeogenesis may influence the ratio of deuterium on the fifth and third carbons of glucose: implications for the use of 2H2O to measure gluconeogenesis in humans. Diabetes. 2008 Jan; 57(1):50-5. Epub 2007 Oct 12.
    View PubMed
  44. Basu R, Shah P, Basu A, Norby B, Dicke B, Chandramouli V, Cohen O, Landau BR, Rizza RA. Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic insulin action in people with type 2 diabetes. Diabetes. 2008 Jan; 57(1):24-31. Epub 2007 Oct 03.
    View PubMed
  45. Nelson RH, Basu R, Johnson CM, Rizza RA, Miles JM. Splanchnic spillover of extracellular lipase-generated fatty acids in overweight and obese humans. Diabetes. 2007 Dec; 56(12):2878-84. Epub 2007 Sep 19.
    View PubMed
  46. Basu A, Charkoudian N, Schrage W, Rizza RA, Basu R, Joyner MJ. Beneficial effects of GLP-1 on endothelial function in humans: dampening by glyburide but not by glimepiride. Am J Physiol Endocrinol Metab. 2007 Nov; 293(5):E1289-95. Epub 2007 Aug 21.
    View PubMed
  47. Butler AE, Galasso R, Meier JJ, Basu R, Rizza RA, Butler PC. Modestly increased beta cell apoptosis but no increased beta cell replication in recent-onset type 1 diabetic patients who died of diabetic ketoacidosis. Diabetologia. 2007 Nov; 50(11):2323-31. Epub 2007 Sep 06.
    View PubMed
  48. Basu R, Dalla Man C, Campioni M, Basu A, Nair KS, Jensen MD, Khosla S, Klee G, Toffolo G, Cobelli C, Rizza RA. Effect of 2 years of testosterone replacement on insulin secretion, insulin action, glucose effectiveness, hepatic insulin clearance, and postprandial glucose turnover in elderly men. Diabetes Care. 2007 Aug; 30(8):1972-8. Epub 2007 May 11.
    View PubMed
  49. Basu R, Pajvani UB, Rizza RA, Scherer PE. Selective downregulation of the high molecular weight form of adiponectin in hyperinsulinemia and in type 2 diabetes: differential regulation from nondiabetic subjects. Diabetes. 2007 Aug; 56(8):2174-7. Epub 2007 May 18.
    View PubMed
  50. Nelson RH, Edgerton DS, Basu R, Roesner JC, Cherrington AD, Miles JM. Triglyceride uptake and lipoprotein lipase-generated fatty acid spillover in the splanchnic bed of dogs. Diabetes. 2007 Jul; 56(7):1850-5. Epub 2007 Apr 06.
    View PubMed
  51. Gandhi GY, Basu R, Dispenzieri A, Basu A, Montori VM, Brennan MD. Endocrinopathy in POEMS syndrome: the Mayo Clinic experience. Mayo Clin Proc. 2007 Jul; 82(7):836-42.
    View PubMed
  52. Bock G, Chittilapilly E, Basu R, Toffolo G, Cobelli C, Chandramouli V, Landau BR, Rizza RA. Contribution of hepatic and extrahepatic insulin resistance to the pathogenesis of impaired fasting glucose: role of increased rates of gluconeogenesis. Diabetes. 2007 Jun; 56(6):1703-11.
    View PubMed
  53. Bock G, Dalla Man C, Campioni M, Chittilapilly E, Basu R, Toffolo G, Cobelli C, Rizza R. Effects of nonglucose nutrients on insulin secretion and action in people with pre-diabetes. Diabetes. 2007 Apr; 56(4):1113-9.
    View PubMed
  54. Basu R, Dalla Man C, Campioni M, Basu A, Nair KS, Jensen MD, Khosla S, Klee G, Toffolo G, Cobelli C, Rizza RA. Two years of treatment with dehydroepiandrosterone does not improve insulin secretion, insulin action, or postprandial glucose turnover in elderly men or women. Diabetes. 2007 Mar; 56(3):753-66.
    View PubMed
  55. Basu R, Dalla Man C, Campioni M, Basu A, Nair KS, Jensen M, Khosla S, Klee G, Toffolo G, Cobelli C, Rizza RA. Effects of two years of testosterone replacement on insulin secrection, insulin action, glucose effectiveness, hepatic insulin clearance and postprandial glucose turnover in elderly men Diabetes Care. 2007; 30:1972-78.
  56. Bock G, Dalla Man C, Campioni M, Chittilapilly E, Basu R, Toffolo G, CobelliC, Rizza R. Effects of non-glucose nutrients on insulin secretion and action in people with pre-diabetes. Diabetes. 2007; 56:1113-9.
  57. Cohen O, Basu R, Bock G, Dalla Man C, Campioni M, Basu A, Toffolo G, Cobelli C, Rizza RA. Prediction of postprandial glycemic exposure: utility of fasting and 2-h glucose measurements alone and in combination with assessment of body composition, fitness, and strength. Diabetes Care. 2006 Dec; 29(12):2708-13.
    View PubMed
  58. Bock G, Dalla Man C, Campioni M, Chittilapilly E, Basu R, Toffolo G, Cobelli C, Rizza R. Pathogenesis of pre-diabetes: mechanisms of fasting and postprandial hyperglycemia in people with impaired fasting glucose and/or impaired glucose tolerance. Diabetes. 2006 Dec; 55(12):3536-49.
    View PubMed
  59. Basu R, Edgerton DS, Singh RJ, Cherrington A, Rizza RA. Splanchnic cortisol production in dogs occurs primarily in the liver: evidence for substantial hepatic specific 11beta hydroxysteroid dehydrogenase type 1 activity. Diabetes. 2006 Nov; 55(11):3013-9.
    View PubMed
  60. Nair KS, Rizza RA, O'Brien P, Dhatariya K, Short KR, Nehra A, Vittone JL, Klee GG, Basu A, Basu R, Cobelli C, Toffolo G, Dalla Man C, Tindall DJ, Melton LJ 3rd, Smith GE, Khosla S, Jensen MD. DHEA in elderly women and DHEA or testosterone in elderly men. N Engl J Med. 2006 Oct 19; 355(16):1647-59.
    View PubMed
  61. Toffolo G, Basu R, Dalla Man C, Rizza R, Cobelli C. Assessment of postprandial glucose metabolism: conventional dual- vs. triple-tracer method. Am J Physiol Endocrinol Metab. 2006 Oct; 291(4):E800-6. Epub 2006 May 23.
    View PubMed
  62. Basu R, Dalla Man C, Campioni M, Basu A, Klee G, Toffolo G, Cobelli C, Rizza RA. Effects of age and sex on postprandial glucose metabolism: differences in glucose turnover, insulin secretion, insulin action, and hepatic insulin extraction. Diabetes. 2006 Jul; 55(7):2001-14.
    View PubMed
  63. Basu R, Singh R, Basu A, Johnson CM, Rizza RA. Effect of nutrient ingestion on total-body and splanchnic cortisol production in humans. Diabetes. 2006 Mar; 55(3):667-74.
    View PubMed
  64. Toffolo G, Campioni M, Basu R, Rizza RA, Cobelli C. A minimal model of insulin secretion and kinetics to assess hepatic insulin extraction. Am J Physiol Endocrinol Metab. 2006 Jan; 290(1):E169-76. Epub 2005 Sep 06.
    View PubMed
  65. Dalla Man C, Toffolo G, Basu R, Rizza RA, Cobelli C. A model of glucose production during a meal. Conf Proc IEEE Eng Med Biol Soc. 2006; 1:5647-50.
    View PubMed
  66. Dalla Man C, Caumo A, Basu R, Rizza R, Toffolo G, Cobelli C. Measurement of selective effect of insulin on glucose disposal from labeled glucose oral test minimal model. Am J Physiol Endocrinol Metab. 2005 Nov; 289(5):E909-14.
    View PubMed
  67. Dalla Man C, Campioni M, Polonsky KS, Basu R, Rizza RA, Toffolo G, Cobelli C. Two-hour seven-sample oral glucose tolerance test and meal protocol - Minimal model assessment of beta-cell responsivity and insulin sensitivity in nondiabetic individuals. Diabetes. 2005 Nov; 54(11):3265-73.
    View PubMed
  68. Basu R, Chandramouli V, Dicke B, Landau B, Rizza R. Obesity and type 2 diabetes impair insulin-induced suppression of glycogenolysis as well as gluconeogenesis. Diabetes. 2005 Jul; 54(7):1942-8.
    View PubMed
  69. Basu R, Singh RJ, Basu A, Chittilapilly EG, Johnson MC, Toffolo G, Cobelli C, Rizza RA. Obesity and type 2 diabetes do not alter splanchnic cortisol production in humans. J Clin Endocrinol Metab. 2005 Jul; 90(7):3919-26. Epub 2005 Apr 05.
    View PubMed
  70. DPT Study Group - Type 1. Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial – Type 1. Diabetes Care. 2005; 28:1068-1076.
  71. Moran A, Basu R, Milla C, Jensen MD. Insulin regulation of free fatty acid kinetics in adult cystic fibrosis patients with impaired glucose tolerance. Metabolism: Clinical & Experimental. 2004 Nov; 53(11):1467-72.
    View PubMed
  72. Dalla Man C, Caumo A, Basu R, Rizza R, Toffolo G, Cobelli C. Minimal model estimation of glucose absorption and insulin sensitivity from oral test: validation with a tracer method. American Journal of Physiology - Endocrinology & Metabolism. 2004 Oct; 287(4):E637-43.
    View PubMed
  73. Basu A, Shah P, Nielsen M, Basu R, Rizza RA. Effects of type 2 diabetes on the regulation of hepatic glucose metabolism. J Investig Med. 2004 Sep; 52(6):366-74.
    View PubMed
  74. Basu R, Basu A, Johnson CM, Schwenk WF, Rizza RA. Insulin dose-response curves for stimulation of splanchnic glucose uptake and suppression of endogenous glucose production differ in nondiabetic humans and are abnormal in people with type 2 diabetes. Diabetes. 2004 Aug; 53(8):2042-50.
    View PubMed
  75. Basu R, Singh RJ, Basu A, Chittilapilly EG, Johnson CM, Toffolo G, Cobelli C, Rizza RA. Splanchnic cortisol production occurs in humans: evidence for conversion of cortisone to cortisol via the 11-beta hydroxysteroid dehydrogenase (11beta-hsd) type 1 pathway. Diabetes. 2004 Aug; 53(8):2051-9.
    View PubMed
  76. Basu R, Schwenk WF, Rizza RA. Both fasting glucose production and disappearance are abnormal in people with "mild" and "severe" type 2 diabetes. Am J Physiol Endocrinol Metab. 2004 Jul; 287(1):E55-62. Epub 2004 Feb 24.
    View PubMed
  77. Adkins A, Basu R, Persson M, Dicke B, Shah P, Vella A, Schwenk WF, Rizza R. Higher insulin concentrations are required to suppress gluconeogenesis than glycogenolysis in nondiabetic humans. Diabetes. 2003 Sep; 52(9):2213-20.
    View PubMed
  78. Zangeneh F, Basu R, Shah P, Arora P, Camilleri M, Rizza RA. Enteral infusion of glucose at rates approximating EGP enhances glucose disposal but does not cause hypoglycemia. Am J Physiol Endocrinol Metab. 2003 Aug; 285(2):E280-6.
    View PubMed
  79. Vella A, Reed AS, Charkoudian N, Shah P, Basu R, Basu A, Joyner MJ, Rizza RA. Glucose-induced suppression of endogenous glucose production: dynamic response to differing glucose profiles. Am J Physiol Endocrinol Metab. 2003 Jul; 285(1):E25-30. Epub 2003 Mar 11.
    View PubMed
  80. Basu R, Breda E, Oberg AL, Powell CC, Dalla Man C, Basu A, Vittone JL, Klee GG, Arora P, Jensen MD, Toffolo G, Cobelli C, Rizza RA. Mechanisms of the age-associated deterioration in glucose tolerance: contribution of alterations in insulin secretion, action, and clearance. Diabetes. 2003 Jul; 52(7):1738-48.
    View PubMed
  81. Dispenzieri A, Kyle RA, Lacy MQ, Rajkumar SV, Therneau TM, Larson DR, Greipp PR, Witzig TE, Basu R, Suarez GA, Fonseca R, Lust JA, Gertz MA. POEMS syndrome: definitions and long-term outcome. Blood. 2003 Apr 1; 101(7):2496-506.
    View PubMed
  82. Shah P, Vella A, Basu A, Basu R, Adkins A, Schwenk WF, Johnson CM, Nair KS, Jensen MD, Rizza RA. Elevated free fatty acids impair glucose metabolism in women: decreased stimulation of muscle glucose uptake and suppression of splanchnic glucose production during combined hyperinsulinemia and hyperglycemia. Diabetes. 2003 Jan; 52(1):38-42.
    View PubMed
  83. Basu R, Di Camillo B, Toffolo G, Basu A, Shah P, Vella A, Rizza R, Cobelli C. Use of a novel triple-tracer approach to assess postprandial glucose metabolism. Am J Physiol Endocrinol Metab. 2003 Jan; 284(1):E55-69.
    View PubMed
  84. Vella A, Shah P, Reed AS, Adkins AS, Basu R, Rizza RA. Lack of effect of exendin-4 and glucagon-like peptide-1-(7,36)-amide on insulin action in non-diabetic humans. Diabetologia. 2002 Oct; 45(10):1410-5. Epub 2002 Sep 05.
    View PubMed
  85. Vella A, Shah P, Basu R, Basu A, Camilleri M, Schwenk WF, Rizza RA. Effect of enteral vs. parenteral glucose delivery on initial splanchnic glucose uptake in nondiabetic humans. Am J Physiol Endocrinol Metab. 2002 Aug; 283(2):E259-66.
    View PubMed
  86. Shah P, Vella A, Basu A, Basu R, Adkins A, Schwenk WF, Johnson CM, Nair KS, Jensen MD, Rizza RA. Effects of free fatty acids and glycerol on splanchnic glucose metabolism and insulin extraction in nondiabetic humans. Diabetes. 2002 Feb; 51(2):301-10.
    View PubMed
  87. DPT Study Group - Type 1. Effects of Insulin in Relatives of Patients with Type 1 Diabetes Mellitus. N Engl J Med. 2002; 346:1685-1691.
  88. Basu R, Basu A, Nair KS. Muscle changes in aging. J Nutr Health Aging. 2002; 6(5):336-41.
    View PubMed
  89. Vella A, Shah P, Basu R, Basu A, Camilleri M, Schwenk WF, Rizza RA. Type I diabetes mellitus does not alter initial splanchnic glucose extraction or hepatic UDP-glucose flux during enteral glucose administration. Diabetologia. 2001 Jun; 44(6):729-37.
    View PubMed
  90. Basu A, Basu R, Shah P, Vella A, Rizza RA, Jensen MD. Systemic and regional free fatty acid metabolism in type 2 diabetes. Am J Physiol Endocrinol Metab. 2001 Jun; 280(6):E1000-6.
    View PubMed
  91. Basu A, Basu R, Shah P, Vella A, Johnson CM, Jensen M, Nair KS, Schwenk WF, Rizza RA. Type 2 diabetes impairs splanchnic uptake of glucose but does not alter intestinal glucose absorption during enteral glucose feeding: additional evidence for a defect in hepatic glucokinase activity. Diabetes. 2001 Jun; 50(6):1351-62.
    View PubMed
  92. Vella A, Shah P, Basu R, Basu A, Camilleri M, Schwenk FW, Holst JJ, Rizza RA. Effect of glucagon-like peptide-1(7-36)-amide on initial splanchnic glucose uptake and insulin action in humans with type 1 diabetes. Diabetes. 2001 Mar; 50(3):565-72.
    View PubMed
  93. Shah P, Vella A, Basu A, Basu R, Schwenk WF, Rizza RA. Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus. J Clin Endocrinol Metab. 2000 Nov; 85(11):4053-9.
    View PubMed
  94. Vella A, Shah P, Basu R, Basu A, Holst JJ, Rizza RA. Effect of glucagon-like peptide 1(7-36) amide on glucose effectiveness and insulin action in people with type 2 diabetes. Diabetes. 2000 Apr; 49(4):611-7.
    View PubMed
  95. Basu A, Basu R, Shah P, Vella A, Johnson CM, Nair KS, Jensen MD, Schwenk WF, Rizza RA. Effects of type 2 diabetes on the ability of insulin and glucose to regulate splanchnic and muscle glucose metabolism: evidence for a defect in hepatic glucokinase activity. Diabetes. 2000 Feb; 49(2):272-83.
    View PubMed
  96. Shah P, Basu A, Basu R, Rizza R. Impact of lack of suppression of glucagon on glucose tolerance in humans. Am J Physiol. 1999 Aug; 277(2 Pt 1):E283-90.
    View PubMed
  97. Basu R, Basu A, Nielsen M, Shah P, Rizza RA. Effect of overnight restoration of euglycemia on glucose effectiveness in type 2 diabetes mellitus. J Clin Endocrinol Metab. 1999 Jul; 84(7):2314-9.
    View PubMed
  98. Nielsen MF, Basu R, Wise S, Caumo A, Cobelli C, Rizza RA. Normal glucose-induced suppression of glucose production but impaired stimulation of glucose disposal in type 2 diabetes: evidence for a concentration-dependent defect in uptake. Diabetes. 1998 Nov; 47(11):1735-47.
    View PubMed
  99. Nielsen MF, Dinneen S, Basu A, Basu R, Alzaid A, Rizza RR. Failure of nocturnal changes in growth hormone to alter carbohydrate tolerance the following morning. Diabetologia. 1998 Sep; 41(9):1064-72.
    View PubMed